Tuesday, April 07, 2020
President Donald Trump has a "small financial interest" in the maker of an anti-malarial drug that he has been touting as a "game changer" in treating coronavirus, according to The New York Times.
Admin's note: Participants in this discussion must follow the site's moderation policy. Profanity will be filtered. Abusive conduct is not allowed.